Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 21,246 shares at $84.50 ($1.8M) on 2024-09-12, disclosed to the SEC on 2024-09-13.
Scheduled sale ($1.8M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GILD | SELL | 2024-10-02 | $168K | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |
| GILD | SELL | 2024-04-02 | $146K | — | Filing → |